Is NASDAQ:AZN a Suitable Choice for Quality Investing?

In this article we will dive into ASTRAZENECA PLC-SPONS ADR (NASDAQ:AZN) as a possible candidate for quality investing. Investors should always do their own research, but we noticed ASTRAZENECA PLC-SPONS ADR showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.

Looking into the quality metrics of ASTRAZENECA PLC-SPONS ADR

• ASTRAZENECA PLC-SPONS ADR has shown strong performance in revenue growth over the past 5 years, with a 15.71% increase. This indicates the company's ability to generate consistent revenue growth and reflects its potential for long-term success.
• ASTRAZENECA PLC-SPONS ADR demonstrates impressive performance in terms of ROIC excluding cash and goodwill, with a 79.12% ratio. This highlights the company's efficient utilization of capital and its focus on maximizing returns for investors.
• With a favorable Debt/Free Cash Flow Ratio of 4.81, ASTRAZENECA PLC-SPONS ADR showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
• With a robust Profit Quality (5-year) ratio of 759.0%, ASTRAZENECA PLC-SPONS ADR highlights its ability to consistently generate high-quality profits. This metric reflects the company's effective management and operational excellence in delivering reliable earnings over the long term.
• With a robust 5-year EBIT growth of 29.65%, ASTRAZENECA PLC-SPONS ADR showcases its ability to consistently expand its operating profitability. This trend indicates the company's effective cost management and revenue generation strategies.
• ASTRAZENECA PLC-SPONS ADR has achieved superior EBIT 5-year growth compared to its Revenue 5-year growth. This demonstrates the company's ability to maximize its profitability through effective cost management and operational strategies.

Fundamental analysis of NASDAQ:AZN

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

Overall AZN gets a fundamental rating of 6 out of 10. We evaluated AZN against 195 industry peers in the Pharmaceuticals industry. While AZN has a great profitability rating, there are some minor concerns on its financial health. AZN has a correct valuation and a medium growth rate.

For an up to date full fundamental analysis you can check the fundamental report of AZN

More ideas for quality investing can be found on ChartMill in our Caviar Cruise screen.

Disclaimer

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.